Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Klaus Umek CRTO Criteo S.A. 13D/A 9.51% 2y
Krishna Kantheti OUST Ouster, Inc. 13G/A 0.2% 2y
Joel E. Cutler IOT Samsara Inc. 13D/A 9.5% 2y
Flawless Management Inc. GASS StealthGas Inc. 13D/A 29.8% 2y
Saudi Economic and Development Securities Company VERO Venus Concept Inc. 13G/A 7.3% 2y
Millennium Management LLC TRVN Trevena, Inc. 13G 4.9% 2y
Warren E. Buffett SIRI Sirius Xm Holdings Inc. 13G 31.01% 2y
SailingStone Capital Partners LLC CMP Compass Minerals International Inc 13G/A 11.55% 2y
Christopher Finn AIFF Firefly Neuroscience, Inc. 13G 5.5% 2y
Corvus Capital Ltd. CDT CDT Equity Inc. 13D/A 31.56% 2y
Bertelsmann SE & Co. KGaA AFYA Afya Ltd 13D/A 71.97% 2y
Bluescape Energy Partners IV GP LLC FEAM 5E Advanced Materials, Inc. 13D/A 37.3% 2y
Ascend Global Investment Fund SPC for and on behalf of Strategic SP FEAM 5E Advanced Materials, Inc. 13D/A 41.3% 2y
Flawless Management Inc. CISS C3is Inc. 13D/A 13.5% 2y
Joseph Pehar GFR Greenfire Resources Ltd. 13G/A 0.5% 2y
Venkat Siva GFR Greenfire Resources Ltd. 13G/A 0.7% 2y
Julian Alexander McIntyre GFR Greenfire Resources Ltd. 13G/A 2.2% 2y
TPG GP A, LLC BCAX Bicara Therapeutics Inc. 13D 5.5% 2y
KERBER WILLIAM XAVIER III PDYN Palladyne AI Corp. 13D/A — 2y
(VOLUNTARY) Kim A. Rivers TRLV Trulieve Cannabis Corp. 13G/A 10.26% 2y
Karpus Management, Inc. WIA Western Asset Inflation-Linked Income Fund 13D/A 32.8% 2y
Patrick C. Eilers AIRJ AirJoule Technologies Corp. 13D/A 12.6% 2y
HLA Investments, LLC HLNE Hamilton Lane INC 13D/A 31% 2y
GENERAL ATLANTIC, L.P. SQSP Squarespace, Inc. 13D/A 16.2% 2y
OPKO HEALTH, INC. WGS GeneDx Holdings Corp. 13D/A 8.06% 2y
TANG CAPITAL MANAGEMENT LLC OMIC Singular Genomics Systems, Inc. Common Stock 13D 14.9% 2y
Caligan Partners LP ALIM Alimera Sciences, Inc. 13D/A 0% 2y
CVI Investments, Inc. VMAR Vision Marine Technologies Inc. 13G 8.4% 2y
Howard Justyn Russell SPT Sprout Social, Inc. 13D/A 5.05% 2y
Peter T. Cangany, Jr. BENF Beneficient 13G 7.4% 2y
Think Investments LP TASK TaskUs, Inc. 13G/A 11.4% 2y
LLR Capital IV, L.P. GPGI GPGI, Inc. 13D/A 0% 2y
Michele D. Logan GPGI GPGI, Inc. 13D/A 2.5% 2y
SRK FUND I, LP ICCC Immucell Corp 13D/A 6.4% 2y
Steel Connect LLC BOOM DMC Global Inc. 13D/A 9.8% 2y
PineBridge GEM II G.P., L.P. IBEX IBEX Ltd 13D/A 11.7% 2y
NOVO HOLDINGS A/S IOBTQ IO Biotech, Inc. 13D/A 8.5% 2y
SYLEBRA CAPITAL LLC PCT PureCycle Technologies, Inc. 13D/A 19.78% 2y
KKR Genetic Disorder L.P. BBIO BridgeBio Pharma, Inc. 13D/A 13.4% 2y
Asteria Vision Fund I, L.P. GRRR Gorilla Technology Group Inc. 13G/A 2.2% 2y
Engaged Capital LLC BRCC BRC Inc. 13D/A 20% 2y
Fairmount Funds Management LLC VRDN Viridian Therapeutics, Inc.DE 13D/A 17.95% 2y
Stone House Capital Management, LLC SPWH Sportsman's Warehouse Holdings, Inc. 13G 5% 2y
James A. Cacioppo JUSH Jushi Holdings Inc. 13D/A 19.07% 2y
TWC Tech Holdings II, LLC CLBT Cellebrite DI Ltd. 13D/A 7.5% 2y
ROTHBERG JONATHAN M QSI Quantum-Si Inc 13D/A 90% 2y
Stone House Capital Management, LLC DBI Designer Brands Inc. 13G 6.3% 2y
NorthCoast Asset Management LLC SPE Special Opportunities Fund, Inc. 13G 14.7% 2y
Equinox Partners Investment Management LLC GTE Gran Tierra Energy Inc. 13G 6.3% 2y
Orin Hirschman INAB In8bio, Inc. 13G/A 4.99% 2y